Summary

C-Reactive Protein Testing Market Summary

The global C-reactive protein testing market size was estimated at USD 5.27 billion in 2024, and is projected to reach USD 6.08 billion by 2033, growing at a CAGR of 1.64% from 2025 to 2033, due to the increasing demand for precision medicine. C-reactive protein is an acute-phase reactant whose levels rise during the early stage of a disease condition, leading to inflammation in the body.

The increasing burden of chronic diseases such as cardiovascular disorders, diabetes, and autoimmune conditions is a major driver of the market. In addition, technological advancements in CRP testing, such as innovations in diagnostic techniques, accuracy of the tests, and ease of accessibility contribute to the major drivers for this market.

The development of point-of-care (POC) CRP testing has transformed disease diagnosis by allowing for quick, on-site testing in clinics, pharmacies, and even home-care environments. These advancements have improved the efficiency of healthcare delivery by shortening result turnaround times and facilitating quicker clinical decision-making. As the demand for personalized medicine increases, technological advancements in CRP testing are anticipated to further propel market growth by enhancing patient outcomes and streamlining diagnostic procedures. According to a report in July 2024, Cornell University proposed an electrochemical impedance spectroscopy (EIS)-based sensor for real-time, fast, and sensitive detection of C-reactive protein (CRP) in interstitial fluid (ISF) using minimally invasive microneedle arrays. This sensor, which could be integrated into a wearable device similar to continuous glucose monitoring, offers a non-invasive, affordable, and simple method for CRP detection.

CRP testing serves as an essential tool for early diagnosis of infections, cardiovascular conditions, and inflammatory disorders, allowing for timely medical intervention. Governments and healthcare organizations around the globe are actively encouraging regular screening programs to detect individuals at risk before serious complications develop. In addition, growing health awareness among individuals has resulted in a higher demand for preventive diagnostic tests, such as CRP testing, as part of regular health check-ups. The shift towards preventive healthcare and early disease detection has been a key factor driving the CRP testing market. As healthcare systems prioritize lowering long-term treatment expenses and enhancing patient outcomes, the early detection of inflammation-related diseases has become increasingly crucial. The increasing focus on proactive health management will further accelerate the adoption of CRP testing in various healthcare settings.

One of the key drivers for expansion in the market for C reactive protein testing is the increasing adoption of these tests and expanding their application in emerging markets. As chronic diseases become more prevalent in these regions due to lifestyle changes, urbanization, and aging populations, the demand for affordable and accessible diagnostic solutions is growing. CRP testing is becoming a standard component of primary healthcare screenings, especially in regions with high rates of infectious diseases and inflammatory disorders. The expansion of diagnostic laboratory services, along with the growing availability of point-of-care testing in rural and underserved areas, is expected to further drive the market in these regions. As healthcare systems in emerging markets continue to advance, the demand for CRP testing will continue to rise, fueling global market growth.

Beyond technological advancements, CRP testing continues to be integral in clinical research applications. For example, in August 2024, a study presented at the European Society of Cardiology Companies utilized hsCRP (high sensitive) measurements to assess cardiovascular risks in women. The findings suggest that evaluating hsCRP levels starting in a woman's 30s can better predict future cardiovascular events, highlighting the importance of early intervention and personalized healthcare strategies. These developments underscore the dynamic nature of CRP testing, reflecting its expanding role in both market growth and clinical practice.

Global C-Reactive Protein Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global C-reactive protein testing market report based on assay, detection range, disease, end use, and region:

• Assay Type Outlook (Revenue, USD Million, 2021 - 2033)
• Immunoturbidimetric Assay
• ELISA
o Clinical
o Nonclinical
• Chemiluminescence Immunoassay
• Others
• Detection Range Outlook (Revenue, USD Million, 2021 - 2033)
• hs-CRP
• Conventional CRP
• cCRP
• Disease Area Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others
• End use Outlook (Revenue, USD Million, 2021 - 2033)
• Clinics
o By Entity
o Physician Offices
o Small Clinics
o Others
o By Settings
o Urban Setting
o Rural Setting
• Hospitals
o Urban Setting
o Rural Setting
• Laboratories
o Urban Setting
o Rural Setting
• Assisted Living Healthcare Facilities
o Urban Setting
o Rural Setting
• Home
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Assay
1.2.2. Detection Range
1.2.3. Disease
1.2.4. End Use
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. C-Reactive Protein Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Rising incidence of chronic and infectious diseases
3.3.1.2. Increasing demand for point-of-care diagnostics
3.3.1.3. Growing demand for portable and automated C-reactive proteins
3.3.2. Market Restraints Analysis
3.3.2.1. Lower detection limit
3.3.2.2. Limitations associated with C-reactive protein techniques
3.4. C-Reactive Protein Testing Market Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. C-Reactive Protein Testing Market: Assay Estimates & Trend Analysis
4.1. C-reactive Protein (CRP) Testing Market: Assay Movement Analysis
4.2. Immunoturbidimetric Assay
4.2.1. Immunoturbidimetric Assay Market, 2021 - 2033 (USD Million)
4.3. ELISA
4.3.1. ELISA Market, 2021 - 2033 (USD Million)
4.3.2. Clinical ELISA
4.3.2.1. Clinical ELISA Market, 2021 - 2033 (USD Million)
4.3.3. Nonclinical ELISA
4.3.3.1. Nonclinical ELISA Market, 2021 - 2033 (USD Million)
4.4. Chemiluminescence Immunoassay
4.4.1. Chemiluminescence Immunoassay Market, 2021 - 2033 (USD Million)
4.5. Others
4.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. C-Reactive Protein Testing Market: Detection Range Estimates & Trend Analysis
5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
5.2. High Sensitivity C-reactive Protein (hs-CRP)
5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2021 - 2033 (USD Million)
5.3. Conventional CRP
5.3.1. Conventional CRP Market, 2021 - 2033 (USD Million)
5.4. Cardiac CRP (cCRP)
5.4.1. Cardiac CRP (CCRP) Market, 2021 - 2033 (USD Million)
Chapter 6. C-Reactive Protein Testing Market Disease Estimates & Trend Analysis
6.1. C-reactive Protein (CRP) Testing Market: Disease Movement Analysis
6.2. Cardiovascular Diseases
6.2.1. Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
6.3. Cancer
6.3.1. Cancer Market, 2021 - 2033 (USD Million)
6.4. Rheumatoid Arthritis
6.4.1. Rheumatoid Arthritis Market, 2021 - 2033 (USD Million)
6.5. Inflammatory Bowel Disease
6.5.1. Inflammatory Bowel Disease Market, 2021 - 2033 (USD Million)
6.6. Endometriosis
6.6.1. Endometriosis Market, 2021 - 2033 (USD Million)
6.7. Lupus
6.7.1. Lupus Market, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. C-Reactive Protein Testing Market End Use Estimates & Trend Analysis
7.1. C-reactive Protein (CRP) Testing Market: End Use Movement Analysis
7.2. Clinics
7.2.1. Clinics Market, 2021 - 2033 (USD Million)
7.2.2. Clinics, by entity
7.2.2.1. Physician offices
7.2.2.1.1. Physician Offices Market, 2021 - 2033 (USD Million)
7.2.2.2. Small clinics
7.2.2.2.1. Small Clinics Market, 2021 - 2033 (USD Million)
7.2.2.3. Others
7.2.2.3.1. Others Market, 2021 - 2033 (USD Million)
7.2.3. Clinics, by setting
7.2.3.1. Urban setting
7.2.3.1.1. Urban Setting Market, 2021 - 2033 (USD Million)
7.2.3.2. Rural settings
7.2.3.2.1. Rural Settings Market, 2021 - 2033 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market, 2021 - 2033 (USD Million)
7.3.2. Urban setting
7.3.2.1. Urban Setting Market, 2021 - 2033 (USD Million)
7.3.3. Rural settings
7.3.3.1. Rural Settings Market, 2021 - 2033 (USD Million)
7.4. Laboratories
7.4.1. Laboratories Market, 2021 - 2033 (USD Million)
7.4.2. Urban setting
7.4.2.1. Urban Setting Market, 2021 - 2033 (USD Million)
7.4.3. Rural settings
7.4.3.1. Rural Settings Market, 2021 - 2033 (USD Million)
7.5. Assisted Living Healthcare Facilities
7.5.1. Assisted Living Healthcare Facilities Market, 2021 - 2033 (USD Million)
7.5.2. Urban setting
7.5.2.1. Urban Setting Market, 2021 - 2033 (USD Million)
7.5.3. Rural settings
7.5.3.1. Rural Settings Market, 2021 - 2033 (USD Million)
7.6. Home
7.6.1. Home Market, 2021 - 2033 (USD Million)
7.7. Others
7.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 8. C-Reactive Protein Testing Market: Regional Estimates & Trend Analysis
8.1. C-Reactive Protein Testing Market Share, By Region, 2024 & 2033 (USD Million)
8.2. North America
8.2.1. North America C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Target Disease Prevalence
8.2.2.3. Competitive Scenario
8.2.2.4. Regulatory Framework
8.2.2.5. Reimbursement Scenario
8.2.2.6. U.S. C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.3.6. Canada C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Reimbursement Scenario
8.2.4.6. Mexico C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3. Europe
8.3.1. Europe C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Scenario
8.3.2.6. UK C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.3.6. Germany C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.4.6. France C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.5.6. Italy C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Spain C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. Denmark C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. Sweden C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Norway C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Scenario
8.4.2.6. Japan C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.3.6. China C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.4.4.6. India C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Scenario
8.4.5.6. Australia C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. South Korea C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Reimbursement Scenario
8.4.7.6. Thailand C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Latin America
8.5.1. Latin America C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Scenario
8.5.2.6. Brazil C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.3.6. Argentina C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. Regulatory Framework
8.6.2.5. Reimbursement Scenario
8.6.2.6. South Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Scenario
8.6.3.6. Saudi Arabia C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Scenario
8.6.4.6. UAE C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Scenario
8.6.5.6. Kuwait C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.5. Abbott
9.5.1. Participant’s Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Developments/ Strategic Initiatives
9.6. Siemens Healthineers AG
9.6.1. Participant’s Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Developments/ Strategic Initiatives
9.7. Danaher Corporation
9.7.1. Participant’s Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Developments/ Strategic Initiatives
9.8. Quest Diagnostics
9.8.1. Participant’s Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Developments/ Strategic Initiatives
9.9 Getein Biotech, Inc
9.8.5. Participant’s Overview
9.8.6. Financial Performance
9.8.7. Product Benchmarking
9.8.8. Recent Developments/ Strategic Initiatives
9.10. Merck KGaAA
9.10.1. Participant’s Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Developments/ Strategic Initiatives
9.11. Zoetis
9.11.1. Participant’s Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Developments/ Strategic Initiatives
9.12. F. Hoffmann-La Roche AG
9.12.1. Participant’s Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Developments/ Strategic Initiatives
9.13. Ortho Clinical Diagnostics
9.13.1. Participant’s Overview
9.13.2. Financial Performance
9.13.3. Product Benchmarking
9.13.4. Recent Developments/ Strategic Initiatives
9.14. Thermo Fisher Scientific, Inc.
9.14.1. Participant’s Overview
9.14.2. Financial Performance
9.14.3. Product Benchmarking
9.14.4. Recent Developments/ Strategic Initiatives
9.15. HORIBA, Ltd
9.15.1. Participant’s Overview
9.15.2. Financial Performance
9.15.3. Product Benchmarking
9.15.4. Recent Developments/ Strategic Initiatives
9.16. Randox Laboratories Ltd.
9.16.1. Participant’s Overview
9.16.2. Financial Performance
9.16.3. Product Benchmarking
9.16.4. Recent Developments/ Strategic Initiatives
9.17. Boditech Med, Inc.
9.17.1. Participant’s Overview
9.17.2. Financial Performance
9.17.3. Product Benchmarking
9.17.4. Recent Developments/ Strategic Initiatives
9.18. Aidian
9.18.1. Participant’s Overview
9.18.2. Financial Performance
9.18.3. Product Benchmarking
9.18.4. Recent Developments/ Strategic Initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of abbreviation
Table 2 Global C-reactive protein market, by region, 2021 - 2033 (USD Million)
Table 3 Global C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 4 Global C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 5 Global C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 6 Global C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 7 North America C-reactive protein market, by country, 2021 - 2033 (USD Million)
Table 8 North America C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 9 North America C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 10 North America C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 11 North America C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 12 U.S. C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 13 U.S. C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 14 U.S. C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 15 U.S. C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 16 Canada C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 17 Canada C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 18 Canada C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 19 Canada C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 20 Mexico C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 21 Mexico C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 22 Mexico C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 23 Mexico C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 24 Europe C-reactive protein market, by country, 2021 - 2033 (USD Million)
Table 25 Europe C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 26 Europe C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 27 Europe C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 28 Europe C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 29 UK C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 30 UK C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 31 UK C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 32 UK C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 33 Germany C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 34 Germany C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 35 Germany C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 36 Germany C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 37 France C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 38 France C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 39 France C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 40 France C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 41 Italy C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 42 Italy C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 43 Italy C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 44 Italy C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 45 Spain C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 46 Spain C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 47 Spain C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 48 Spain C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 49 Denmark C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 50 Denmark C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 51 Denmark C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 52 Denmark C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 53 Sweden C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 54 Sweden C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 55 Sweden C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 56 Sweden C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 57 Norway C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 58 Norway C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 59 Norway C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 60 Norway C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 61 Asia Pacific C-reactive protein market, by country, 2021 - 2033 (USD Million)
Table 62 Asia Pacific C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 63 Asia Pacific C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 64 Asia Pacific C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 65 Asia Pacific C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 66 Japan C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 67 Japan C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 68 Japan C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 69 Japan C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 70 China C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 71 China C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 72 China C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 73 China C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 74 India C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 75 India C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 76 India C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 77 India C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 78 Australia C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 79 Australia C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 80 Australia C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 81 Australia C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 82 South Korea C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 83 South Korea C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 84 South Korea C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 85 South Korea C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 86 Thailand C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 87 Thailand C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 88 Thailand C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 89 Thailand C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 90 Latin America C-reactive protein market, by country, 2021 - 2033 (USD Million)
Table 91 Latin America C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 92 Latin America C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 93 Latin America C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 94 Latin America C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 95 Brazil C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 96 Brazil C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 97 Brazil C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 98 Brazil C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 99 Argentina C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 100 Argentina C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 101 Argentina C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 102 Argentina C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 103 MEA C-reactive protein market, by country, 2021 - 2033 (USD Million)
Table 104 MEA C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 105 MEA C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 106 MEA C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 107 MEA C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 108 South Africa C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 109 South Africa C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 110 South Africa C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 111 South Africa C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 112 Saudi Arabia C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 116 UAE C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 117 UAE C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 118 UAE C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 119 UAE C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
Table 120 Kuwait C-reactive protein market, by assay, 2021 - 2033 (USD Million)
Table 121 Kuwait C-reactive protein market, by disease, 2021 - 2033 (USD Million)
Table 122 Kuwait C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
Table 123 Kuwait C-reactive protein market, by end-use, 2021 - 2033 (USD Million)List of Figures

Fig. 1 C-reactive protein testing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot - 1
Fig. 14 Segment snapshot - 2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 C-reactive protein testing market: Assay outlook key takeaways
Fig. 20 C-reactive protein testing market: Assay movement analysis
Fig. 21 Immunoturbidimetric assay market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 ELISA market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Chemiluminescence Immunoassay (CLIA ) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Other Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 C-reactive protein market: Detection Range outlook key takeaways
Fig. 26 C-reactive protein market: Detection Range movement analysis
Fig. 27 hs-CRP market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Conventional CRP market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 cCRP market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 C-reactive protein market: Disease outlook key takeaways
Fig. 31 C-reactive protein market: Disease movement analysis
Fig. 32 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Rheumatoid arthritis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Inflammatory bowel disease Testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Endometriosis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Lupus market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 C-reactive protein market: End Use outlook key takeaways
Fig. 40 C-reactive protein market: End Use movement analysis
Fig. 41 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Physician Office clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Small clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Others clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Assisted living healthcare facilities market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Home market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Regional marketplace outlook, 2024 & 2033 (USD Million)
Fig. 51 Regional marketplace: Key takeaways
Fig. 52 North America C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 U.S. C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Canada C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Mexico C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Europe C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 UK C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Germany C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 France C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Spain C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Italy C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Denmark C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Sweden C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Norway C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Asia Pacific C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Japan C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 China C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 India C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Australia C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 South Korea C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Thailand C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Market participant categorization
Fig. 91 C-reactive protein testing market position analysis, 2024
Fig. 92 Strategic framework